Enforcement record
Criminal Accusation disclosure naming セイルインターナショナル株式会社
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Criminal Accusation
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
10 March 2017
RegBase evidence report
Japanese public-record enforcement check
Saveable record of the published action, regulator source, source status, and review notes for internal compliance files.
- Report ID
- RB-EN-ENFORCEMENT-OTHER-SEIRUINTANA-202607241618
- Generated at
- 25 July 2026 at 01:18
- Record URL
- https://regbase.jp/en/enforcement/other-seiruintanasiyonaru-20170310
1. Review Summary
| Disclosure name | セイルインターナショナル株式会社 | Corporate Number | Not stated in the disclosure |
|---|---|---|---|
| Enforcement record | 1 record | Other confirmed records for this company | Outside this report's scope |
| Action date | 10 March 2017 | Authority | Ministry of Health, Labour and Welfare |
| Law | Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices | Action type | Criminal Accusation |
| Source status | Preserved public-source archive recorded | ||
This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.
2. Published Information
| Published name | セイルインターナショナル株式会社 |
|---|
3. Enforcement Record
| Target name in disclosure | セイルインターナショナル株式会社 |
|---|---|
| Authority | Ministry of Health, Labour and Welfare (厚生労働省) |
| Law / action type | Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices / Criminal Accusation |
| Action / announcement date | Action: 10 March 2017 / Announcement: 28 March 2026 |
| English summary | It is suspected that the actions of the accused company violate Article 23-2, Paragraph 1; Article 23-2-3, Paragraph 1; and Article 55, Paragraph 2, which is applied mutatis mutandis under Article 64 of the Act against Unjustifiable Premiums and Misleading Representations, and also violate Articles 84, Item 4; 84, Item 18; and 86, Paragraph 1, Item 4 of the same Act. |
| Original Japanese text | 被告発会社の行為が、医薬品医療機器等法第23条の2第1項、第23条の2の3第1項及び第64条で準用する第55条第2項に違反し、第84条第4号及び第18号並びに第86条第1項第4号に該当する疑いがある。 |
| Official source | https://www.mhlw.go.jp/stf/houdou/0000154531.html |
| Source archive | https://kiroku.today/a/8ef975a77chf0grk |
| Extraction / evidence timestamps | Extracted: 25 April 2026 at 08:35 / Evidence checked: 25 April 2026 at 08:35 / Archive captured: 12 July 2026 at 15:33 |
4. Business Location and Permit Details
No additional structured business-location or permit fields are recorded for this disclosure.
5. Other Confirmed Records for This Company
This report covers the single government disclosure shown on this page.
Reviewer Notes
| Reviewer | Team / company | ||
|---|---|---|---|
| Review purpose | |||
| Additional notes | |||
- □ Official source URL or archived source was checked.
- □ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
- □ This document is understood as a public-record evidence file, not a credit decision or legal opinion.
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Free report
Save the disclosure record naming セイルインターナショナル株式会社
Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.
Preserved evidence by Kiroku
Review the preserved source for セイルインターナショナル株式会社
Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.
For developers: JSON integration details
You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.
Action summary
- Company
- セイルインターナショナル株式会社Japanese onlyOriginal: セイルインターナショナル株式会社
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices医薬品医療機器等法
- Action type
- Criminal Accusation告発
- Action date
- 10 March 2017
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品・医療機器
Violation
It is suspected that the actions of the accused company violate Article 23-2, Paragraph 1; Article 23-2-3, Paragraph 1; and Article 55, Paragraph 2, which is applied mutatis mutandis under Article 64 of the Act against Unjustifiable Premiums and Misleading Representations, and also violate Articles 84, Item 4; 84, Item 18; and 86, Paragraph 1, Item 4 of the same Act.
Show original Japanese text
被告発会社の行為が、医薬品医療機器等法第23条の2第1項、第23条の2の3第1項及び第64条で準用する第55条第2項に違反し、第84条第4号及び第18号並びに第86条第1項第4号に該当する疑いがある。
Compliance context
HighThe authority announced a criminal accusation or referral based on the disclosed facts.
Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices.
Escalate for legal review and check whether later public records changed the status of the matter.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-04-24T23:35:45.154+00:00
- Evidence checked
- 2026-04-24T23:35:45.154+00:00
- Archive captured
- 2026-07-12T06:33:04.892176+00:00
Show audit JSON
{
"record": {
"id": "0e9c6062-6ae3-48a7-9436-c36c4b997fe9",
"url": "https://regbase.jp/en/enforcement/other-seiruintanasiyonaru-20170310",
"company_name_original": "セイルインターナショナル株式会社",
"company_name_registry": null,
"corporate_number": null,
"law": {
"ja": "医薬品医療機器等法",
"en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
},
"action_type": {
"ja": "告発",
"en": "Criminal Accusation"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "unresolved",
"confidence": 85,
"method": "nta_strict_name_nationally_unique",
"method_label": "nta_strict_name_nationally_unique",
"notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (セイルインターナショナル株式会社). No Corporate Number was present in the disclosure, so this remains a likely match."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "High",
"actionMeaning": "The authority announced a criminal accusation or referral based on the disclosed facts.",
"practicalNote": "Escalate for legal review and check whether later public records changed the status of the matter.",
"lawContext": "Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-seiruintanasiyonaru-20170310",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000154531.html",
"officialDocumentUrl": null,
"archiveUrl": "https://kiroku.today/a/8ef975a77chf0grk",
"archivedSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000154531.html",
"archiveCapturedAt": "2026-07-12T06:33:04.892176+00:00",
"extractedAt": "2026-04-24T23:35:45.154+00:00",
"translatedAt": "2026-05-01T06:50:47.746+00:00",
"evidenceCheckedAt": "2026-04-24T23:35:45.154+00:00",
"generatedAt": "2026-07-24T16:18:56.668Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.